Figure 2
Figure 2. Overall survival of (A) ET versus prePMF patients, (B) patients without versus patients with one or more high molecular risk mutations, (C) ET patients with and without high molecular risk mutations and (D) prePMF patients with and without high molecular risk mutations.

Overall survival of (A) ET versus prePMF patients, (B) patients without versus patients with one or more high molecular risk mutations, (C) ET patients with and without high molecular risk mutations and (D) prePMF patients with and without high molecular risk mutations.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal